Mouse models engrafted with high LIF-secreting hematopoietic cells were seen to develop a fatal cachexia phenotype, and non-human primates injected with high doses of recombinant LIF experienced rapid loss of subcutaneous adipose, which resolved when treatment was terminated [129,130]. The gene discussed is LIF; the disease is Cachexia.